药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Anagliptin
The risk or severity of angioedema can be increased when Linagliptin is combined with Anagliptin.
Tetracosactide
Gemigliptin
The risk or severity of angioedema can be increased when Linagliptin is combined with Gemigliptin.
Tetracosactide
Carmegliptin
The risk or severity of angioedema can be increased when Linagliptin is combined with Carmegliptin.
Tetracosactide
Omarigliptin
The risk or severity of angioedema can be increased when Linagliptin is combined with Omarigliptin.
Tetracosactide
Teneligliptin
The risk or severity of angioedema can be increased when Linagliptin is combined with Teneligliptin.
Tetracosactide
Imidapril
The risk or severity of angioedema can be increased when Linagliptin is combined with Imidapril.
Tetracosactide
Dutogliptin
The risk or severity of angioedema can be increased when Linagliptin is combined with Dutogliptin.
Tetracosactide
Enalaprilat
The risk or severity of angioedema can be increased when Linagliptin is combined with Enalaprilat.
Tetracosactide
Sacubitril
The risk or severity of angioedema can be increased when Linagliptin is combined with Sacubitril.
Tetracosactide
Azilsartan medoxomil
The risk or severity of angioedema can be increased when Azilsartan medoxomil is combined with Linagliptin.
Tetracosactide
Gosogliptin
The risk or severity of angioedema can be increased when Gosogliptin is combined with Linagliptin.
Tetracosactide
Amediplase
The risk or severity of angioedema can be increased when Amediplase is combined with Linagliptin.
Tetracosactide
Lanoteplase
The risk or severity of angioedema can be increased when Lanoteplase is combined with Linagliptin.
Tetracosactide
Alogliptin
The risk or severity of angioedema can be increased when Alogliptin is combined with Linagliptin.
Tetracosactide
Icatibant
The risk or severity of angioedema can be increased when Icatibant is combined with Linagliptin.
Tetracosactide
Bisegliptin
The risk or severity of angioedema can be increased when Bisegliptin is combined with Linagliptin.
Tetracosactide
AMG-222
The risk or severity of angioedema can be increased when AMG-222 is combined with Linagliptin.
Tetracosactide
Vildagliptin
The risk or severity of angioedema can be increased when Vildagliptin is combined with Linagliptin.
Tetracosactide
Saprisartan
The risk or severity of angioedema can be increased when Saprisartan is combined with Linagliptin.
Tetracosactide
Forasartan
The risk or severity of angioedema can be increased when Forasartan is combined with Linagliptin.